Fins & Tails, Bits & Bobbers ... Vol 5-2

New Distributor for HALAMID® AQUA (chloramine-T): Under Chloramine-T INAD 9321 two products (HALAMID® AQUA and Actamide) are authorized for use by INAD participants. Recently, Western Chemical Inc., Ferndale, Washington USA
announced that they are the new distributor for HALAMID® AQUA (formerly distributed by International Specialty, Inc.). The contact person for HALAMID® AQUA at Western Chemical is Ron Malnor, and Ron's complete contact information can be found on the chloramine-T fact sheet located on the AADAP website (

Attention Potential SLICE® (emamectin benzoate) INAD Participants: For some time now, the AADAP Office and Intervet Schering-Plough Animal Health have been working hand-in-hand to address potential environmental discharge-related concerns expressed by FDA with respect to the use of SLICE® under INAD authorization. These concerns have to date precluded FDA from granting treatment authorization for the use of SLICE® under INAD 11-370. The good news is that we believe that FDA‟s aforementioned concerns have been adequately addressed, and that treatment authorization for the use of SLICE® under INAD 11-370 is anticipated within a couple/three months! If you are interested in participating under the SLICE® INAD11-370 and have not already filled out a site-specific SLICE® Environmental Assessment (EA) Questionnaire for your facility, we suggest that you do so at your earliest convenience. To obtain a copy of the EA Questionnaire, refer to the following webpage:

It is important to note that a completed EA Questionnaire for each participating facility will need to be received by the AADAP Office prior to actual treatment of fish under SLICE® INAD 11-370. Additionally, each facility will also need to notify and receive agreement/confirmation/concurrence from their local NPDES permitting office, or their regional EPA office if EPA has jurisdiction, that SLICE® treatment is authorized (click here to determine whether your state has NPDES permitting jurisdiction).

Update on BENZOAK® INAD 11-740 and AQUI-S® E INAD 11-741: The purpose of these INADs is to allow for their use to anesthetize freshwater and marine finfish, and more specifically, for use to sedate fish to the “handleable-stage” of anesthesia. Current INAD authorizations for BENZOAK® and AQUI-S® E do not allow for the slaughter and/or release of treated animals. Recently, the AADAP Office submitted amended authorization requests to FDA for both INADs requesting the establishment of a post-treatment investigational withdrawal time and authorization to slaughter and/or release treated animals. We are anticipating a reply from FDA within the next few months, and hopefully, at that time these INADs will be available for field use to generate supportive efficacy and safety data. Stay tuned!









Double click to select button
©Copyright 2006 US Fish & Wildlife Service All Rights Reserved


Disclaimer: Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.

For more information, feel free to Contact Us
LAST UPDATED: 16-Jan-2013